食道癌患者においてはCRPとアルブミンの比率(CRA)が最もOSを予測した.疾患別に少し違うのかな.どうだろ. https://t.co/ggCV51eXND
RT @AnnSurgOncol: OCTOBER ISSUE:Prognostic Value of Preoperative Systemic Immunoinflammatory Measures in Patients with #EsophagealCancer. h…
RT @AnnSurgOncol: OCTOBER ISSUE:Prognostic Value of Preoperative Systemic Immunoinflammatory Measures in Patients with #EsophagealCancer. h…
RT @AnnSurgOncol: OCTOBER ISSUE:Prognostic Value of Preoperative Systemic Immunoinflammatory Measures in Patients with #EsophagealCancer. h…
RT @AnnSurgOncol: OCTOBER ISSUE:Prognostic Value of Preoperative Systemic Immunoinflammatory Measures in Patients with #EsophagealCancer. h…
RT @AnnSurgOncol: OCTOBER ISSUE:Prognostic Value of Preoperative Systemic Immunoinflammatory Measures in Patients with #EsophagealCancer. h…
RT SocSurgOnc RT AnnSurgOncol: OCTOBER ISSUE:Prognostic Value of Preoperative Systemic Immunoinflammatory Measures in Patients with #EsophagealCancer. https://t.co/rNG91cokYN McMastersKelly SocSurgOnc https://t.co/iDQRNyQgLB
RT @AnnSurgOncol: OCTOBER ISSUE:Prognostic Value of Preoperative Systemic Immunoinflammatory Measures in Patients with #EsophagealCancer. h…
RT @AnnSurgOncol: OCTOBER ISSUE:Prognostic Value of Preoperative Systemic Immunoinflammatory Measures in Patients with #EsophagealCancer. h…
OCTOBER ISSUE:Prognostic Value of Preoperative Systemic Immunoinflammatory Measures in Patients with #EsophagealCancer. https://t.co/dO4fbL9yNQ @McMastersKelly @SocSurgOnc https://t.co/GBShnxMw8s